Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision

被引：0
|
作者：
Onal, Cem [1 ,2 ]
Elmali, Aysenur [2 ]
Guler, Ozan Cem [1 ]
机构：
[1] Baskent Univ, Fac Med, Adana Dr Turgut Noyan Res & Treatment Ctr, Dept Radiat Oncol, TR-01120 Adana, Turkiye
[2] Baskent Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkiye
来源：
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY | 2024年 / 45卷
关键词：
D O I：
10.1016/j.ctro.2024.100754
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prevalence of oligoprogressive, metastatic castration-resistant prostate cancer (mCRPC) amenable to stereotactic ablative radiotherapy (SABR) in men undergoing abiraterone acetate (AA) therapy.
    McDonald, Erica
    Cheng, Sierra
    Arciero, Vanessa Sarah
    Saluja, Ronak
    Zukotynski, Katherine A.
    Cheung, Patrick
    Emmenegger, Urban
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] PSMA-Targeted Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
    Sartor, A. Oliver
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 494 - 496
  • [23] Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
    Mai, Lixin
    Zhang, Zitong
    Li, Yonghong
    Liu, Ruiqi
    Li, Jibin
    Huang, Sijuan
    Lin, Maosheng
    Liu, Boji
    Cao, Wufei
    Wu, Jianhua
    Liu, Mengzhong
    Zhou, Fangjian
    Liu, Yang
    He, Liru
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] MDT perspective: innovative applications of stereotactic body radiation therapy in metastatic castration-resistant prostate cancer
    Hahn, Andrew W.
    Aparicio, Ana
    Jadvar, Hossein
    Poon, Darren M. C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024,
  • [25] METASTASES-DIRECTED STEREOTACTIC RADIOTHERAPY FOR OLIGOMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER: MULTICENTRE SERIES OF 86 PATIENTS/117 LESIONS
    Bonu, Marco Lorenzo
    Triggiani, Luca
    Tomasini, Davide
    Ingrosso, Gianluca
    Borghetti, Paolo
    Trippa, Fabio
    Lancia, Andrea
    Detti, Beatrice
    Matrone, Fabio
    Fanetti, Giuseppe
    Pasqualetti, Francesco
    Magli, Alessandro
    Bruni, Alessio
    Mazzeo, Ercole
    Franzese, Ciro
    Francolini, Guido
    Mazzola, Rosario
    ANTICANCER RESEARCH, 2019, 39 (03) : 1550 - 1550
  • [26] Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer
    La, Jennifer
    Wang, Lin
    Corrigan, June K.
    Lang, Deborah
    Lee, Michelle H.
    Do, Nhan V.
    Brophy, Mary T.
    Paller, Channing J.
    Fillmore, Nathanael R.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [27] Olaparib in Metastatic Castration-Resistant Prostate Cancer
    Biswas, Bivas
    Ganguly, Sandip
    Ghosh, Joydeep
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1174 - 1175
  • [28] Biomarkers in Metastatic Castration-resistant Prostate Cancer
    Miller, K.
    AKTUELLE UROLOGIE, 2015, 46 (01) : 66 - 70
  • [29] Olaparib in metastatic castration-resistant Prostate Cancer
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02)
  • [30] Olaparib for Metastatic Castration-Resistant Prostate Cancer
    de Bono, J.
    Mateo, J.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S.
    Chi, K. N.
    Sartor, O.
    Agarwal, N.
    Olmos, D.
    Thiery-Vuillemin, A.
    Twardowski, P.
    Mehra, N.
    Goessl, C.
    Kang, J.
    Burgents, J.
    Wu, W.
    Kohlmann, A.
    Adelman, C. A.
    Hussain, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2091 - 2102
12345